Lin C Wang

US Patent:

6856719, Feb 15, 2005

Filed:

Mar 11, 2002

Appl. No.:

10/097112

Inventors:

Lin T. Wang - Fremont CA, US
Yale Zhang - Sunnyvale CA, US
Yuqiao Liu - Sunnyvale CA, US
Wei-Shin Tsay - Saratoga CA, US

Assignee:

Alliance Fiber Optic Products, Inc. - Sunnyvale CA

International Classification:

G02B006/26

US Classification:

385 17, 398130

Abstract:

The inventions invention relates to a generic re-configurable WDM optical cross connection device which may be viewed as an optical network element comprising transport interfaces optionally along with tributary interfaces. An switch system includes a plurality of switch modules each essentially including a pair of R-channel input collimators on one side and a pair of R-channel output collimators on the other side with a switching prism moveably positioned therebetween in an existence/active or non-existence/inactive manner. A pair of input fibers are respectively connected to the two input collimators and an pair of output fibers are respectively connected t the two output collimators. A plurality of jumper fibers cascading said switch modules together.

US Patent:

7553653, Jun 30, 2009

Filed:

Sep 19, 2005

Appl. No.:

11/230374

Inventors:

Emilio Kakkis - Novato CA, US
Daniel Oppenheimer - Castro Valley CA, US
Paul Fitzpatrick - Albany CA, US
Robert Heft - D.D.O., CA
Alejandra Gamez - San Diego CA, US
Lin Wang - San Diego CA, US
Woomi Kim - Busan, KR
Mary Straub - Malibu CA, US
Marianne Patch - San Diego CA, US
Raymond C. Stevens - La Jolla CA, US

Assignee:

BioMarin Pharmaceutical Inc. - Novato CA
The Scripps Research Institute - La Jolla CA

International Classification:

C12N 9/88

US Classification:

435232

Abstract:

The present invention pertains to the use of the protein phenylalanine ammonia-lyase, as well as the biologically-active derivatives of the said protein for preventing or treating diseases associated with a phenylalanine imbalance in a human or animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating a phenylalanine imbalance in vivo. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting more therapeutically-effective variants of said protein as well as to the selected variants themselves.

US Patent:

20230010287, Jan 12, 2023

Filed:

Jul 7, 2022

Appl. No.:

17/859770

Inventors:

- Menlo Park CA, US
Robert H. Reamey - Menlo Park CA, US
Lin Wang - Menlo Park CA, US
Fabian Block - Menlo Park CA, US
Kurt Patterson - Menlo Park CA, US
Brittany Ann Rohrman - Menlo Park CA, US
Andrew Sparks - Menlo Park CA, US
Evan Hurowitz - Menlo Park CA, US
Joan Wilson - Menlo Park CA, US

International Classification:

C12Q 1/6869

Abstract:

The present invention provides methods and compositions for carrying out nucleic acid sequencing, particularly paired-end sequencing. The methods use concatemeric sequencing templates that can be produced by rolling circle amplification of asymmetric circular nucleic acids having a central double-stranded region comprising a target nucleic acid sequence that is connected at each end to form a circular construct.